Not just POH building its pain portfolio?
15/01/2013
Neura Therapeutik announced today the securing of terms on NL-001, an abuse-deterrent, long-acting opioid analgesic and that studies conducted on NL-001 comply with recent FDA draft guidance. Issued last week, this guidance is intended to assist pharmaceutical companies who wish to develop abuse deterrent opioid formulations.
http://www.heraldonline.com/2013/01/15/4543808/abuse-deterrent-opioid-from-neura.html
neura therapeutik news
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $369 | 138.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 56 | 96190952 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 59980558 | 19 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |